HDR Brachytherapy at a Dose of 21 Gy in a Single Fraction for Patients with Low-Intermediate Risk Prostate Cancer: Initial Toxicity Outcomes

Authors :: Peter Y. Chen
Gary S. Gustafson
Beth Mitchell
Hong Ye
Daniel J. Krauss
Melissa Wienczewski
Amy Limbacher
Evelyn Sebastian
Matthew P. Johnson
Source :: Brachytherapy. 18:S54
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: medicine.medical_specialty
business.industry
medicine.medical_treatment
Brachytherapy
Urology
medicine.disease
Single fraction
Prostate cancer
Oncology
Toxicity
medicine
Radiology, Nuclear Medicine and imaging
Intermediate risk
business

Full Text Access

Tools